Pharmacokinetics and Safety of Tenofovir in HIV-Infected Women During Labor and Their Infants During the First Week of Life
Mark Mirochnick(Government of the United States of America), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Casey Herron(Michigan Medicine), Johnstone Kumwenda(Blantyre Institute for Community Ophthalmology), Karin Nielsen‐Saines(University of California, Los Angeles), Lynda Emel(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Taha E. Taha(Blantyre Institute for Community Ophthalmology), Régis Kreitchmann(Irmandade da Santa Casa de Misericórdia de São Paulo), Breno Santos(UCLA Medical Center), Susan H. Eshleman(Johns Hopkins University), Kathleen George(Family Health International 360), Esaú João(Hospital Federal dos Servidores do Estado), Mary Glenn Fowler(Johns Hopkins University), Paul Richardson(Johns Hopkins University), Jorge Pinto(Universidade Federal de Minas Gerais), Teresa L. Parsons(Johns Hopkins University), Sarah E. Hudelson(Johns Hopkins University), Paul Sato(Family Health International 360), Brian P. Kearney(Belfast Health and Social Care Trust)
Cited by 67
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|896